About Plexymer
Plexymer is a Healthcare company based in Plainfield (United States) founded in 2021. It develops custom polymer excipients using AI and robotics for pharmaceutical proteins. It operates on a B2B and Service-based model in Healthcare and Chemicals & Materials sectors. Plexymer offers products and services including Custom Excipients and Excipient Design Platform. Its focus areas include Biotechnology, Pharmaceutical Tech, Protein Formulation and Excipient Design. Its competitors include Archon Bio, Etcembly, SQALE, Neuromathix and Sprectroo and 2 more; 2 of its 7 listed competitors have raised funding.
Company details
Plexymer is a startup based at Rutgers University that specializes in AI-enabled technology for creating custom polymer excipients tailored to sensitive proteins. They combine automated combinatorial chemistry and machine learning to streamline excipient design. Customers provide proteins and assays, and Plexymer handles formulation without commitments, serving the pharmaceutical industry for improved protein products.
- Headquarters Plainfield, United States
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Website plexymer.com
Products & Services of Plexymer
Plexymer offers a comprehensive portfolio of products and services, including Custom Excipients and Excipient Design Platform.
AI-driven design of tailored polymer excipients for proteins
Automated system for polymer-protein hybrid development
Competitors of Plexymer
Plexymer has 7 listed competitors in our database, 2 of them funded. They include Archon Bio, Etcembly, SQALE, Neuromathix and Sprectroo, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| archon.bio | 2023 | Seattle, United States | $20M | – | Provider of computational platform to develop protein therapeutics | |
| etcembly.io | 2020 | Harwell, United Kingdom | $12.66M | – | Provider of AI-based platform to engineer novel T cell receptors for cancer immunotherapy | |
| sqale.ai | 2023 | Copenhagen, Denmark | – | – | Provides bioprocess optimization services for microalgae and precision fermentation companies. | |
| neuromathix.com | 2001 | Brisbane, Australia | – | – | Offers decision support software for personalized healthcare models based on patient data. | |
| sprectroo.com | 2022 | Santa Clara, United States | – | – | Sprectroo is an AI-driven platform for drug derivatization and repurposing. | |
| protains.com | 2024 | – | – | – | AI-driven platform for drug discovery using algorithms and computing resources. | |
| csrnd.com | 1995 | Zurich, Switzerland | – | – | AI-driven tools for accelerating drug discovery processes. |
Detailed competitors of Plexymer
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Plexymer (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Plexymer
Plexymer was founded in 2021.
Plexymer is headquartered in Plainfield, United States. It is registered at Plainfield, New Jersey, United States.
Plexymer is a startup based at Rutgers University that specializes in AI-enabled technology for creating custom polymer excipients tailored to sensitive proteins. They combine automated combinatorial chemistry and machine learning to streamline excipient design. Customers provide proteins and assays, and Plexymer handles formulation without commitments, serving the pharmaceutical industry for improved protein products.
Plexymer's top competitors include Etcembly, Archon Bio and SQALE.
Plexymer offers Custom Excipients and Excipient Design Platform.